Met Life Investment Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$13.06 - $15.0 $73,266 - $84,150
5,610 New
5,610 $82,000
Q3 2023

May 09, 2024
BUY
$11.6 - $12.52 $65,076 - $70,237
5,610 New
5,610 $69,000
Q2 2023

Apr 29, 2024
BUY
$12.02 - $13.07 $67,432 - $73,322
5,610 New
5,610 $69,000
Q2 2023

Aug 10, 2023
BUY
$12.02 - $13.07 $67,432 - $73,322
5,610 New
5,610 $69,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email